Sorin Buga, MD
Clinical Professor, Department of Supportive Care Medicine
Program Director, COH Hospice and Palliative Medicine Fellowship
City of Hope
Duarte, CA

David Copenhaver, MD, MPH
Chief, Division of Pain Medicine
Director, Cancer Pain Management & Supportive Care
Director, Pain Tele-Health programs
Clinical Professor, Division of Pain Medicine
UC Davis Health
Sacramento, CA

David S. Craig, PharmD
Pharmacist Lead, Acute Pain and Supportive Care Medicine
Moffitt Cancer Center
Tampa, FL

Dwain Fehon, PsyD
Professor of Psychology
Chief Psychologist, Psychiatric Services, Yale New Haven Hospital;
Director, Behavioral Medicine Service
Yale School of Medicine 
New Haven, CT

Myra Glajchen, DSW, MSW, BSW, ACSW, APHSW-C 
Director of Education and Training
ESPEC Project Director
Associate Program Director, Fellowship Training Program
MJHS Institute for Innovation in Palliative Care
New York, NY

Elizabeth Prsic, MD
Director, Adult Inpatient Palliative Care 
Firm Chief, Medical Oncology
Yale Cancer Center
Assistant Professor, Yale School of Medicine
New Haven, CT

Carey Ramirez, ANP-C, ACHPN
Manager, Advanced Practice 
Supportive Care Medicine 
City of Hope 
Duarte, CA

Erin Vipler, MD
Assistant Professor, Medicine-Internal Medicine
University of Colorado Hospital
Aurora, CO

Jeanie Youngwerth, MD, FAAHPM
Associate Professor of Medicine
UCH Medical Staff President
Associate Program Director, Colorado Palliative Medicine Fellowship
Director, Palliative Care Service
Department of Medicine
University of Colorado Anschutz Medical Campus
Aurora, CO
 

NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions  

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

The faculty listed below have no financial relationships with ineligible companies to disclose.

David Copenhaver, MD, MPH
Dwain Fehon, PsyD
Myra Glajchen, DSW, MSW, BSW, ACSW, APHSW-C
Elizabeth Prsic, MD
Carey Ramirez, ANP-C, ACHPN
Erin Vipler, MD
Jeanie Youngwerth, MD, FAAHPM

The faculty listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Sorin Buga, MD
Bausch Health US LLS: Non-CE Consulting

David S. Craig, PharmD
PCORI: Contract Research
Seikagaku Corporation: Non-CE Consulting (relationship ended August 2024)
Syneos Health, LLC: Non-CE Consulting (relationship ended February 2023)
USM, LLC: Non-CE Consulting (relationship ended May 2023)

NCCN and The France Foundation Staff Disclosures

None of the planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.